content: <HTML>
  <HEAD>
       <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
  on March 25, 2024</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>
  
  <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>UNITED
  STATES</B></FONT></P>
  
  <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>SECURITIES
  AND EXCHANGE COMMISSION</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>FORM
  S-8</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT <BR>
  UNDER THE SECURITIES
  ACT OF 1933</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Allarity
  Therapeutics, Inc.</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center; width: 49%"><B>Delaware</B></TD>
      <TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; width: 2%">&nbsp;</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center; width: 49%"><B>87-2147982</B></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">incorporation or organization)</P></TD>
      <TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</P></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; width: 49%">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>24 School Street, 2<SUP>nd </SUP>Floor</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Boston, MA</B></P></TD>
      <TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; width: 2%">&nbsp;</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; width: 49%">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>02108</B></P></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt; text-align: center">(Address of Principal Executive Offices)</TD>
      <TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD STYLE="font-size: 10pt; text-align: center">(Zip Code)</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Allarity Therapeutics, Inc. 2021 Equity Incentive
  Plan</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full title of the plan)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Thomas Jensen</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chief Executive Officer</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>c/o Allarity Therapeutics, Inc.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>24 School Street, 2<SUP>nd</SUP> Floor</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Boston, MA 02108 </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(401) 426-4664 </B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address and telephone number, including
  area code, of agent for service)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Copy to:</I></B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>William N. Haddad, Esq.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Arif Soto, Esq.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Venable LLP</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>151 W. 42<SUP>nd</SUP> Street, 49<SUP>th</SUP>
  Floor</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10036</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(212) 307-5500</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
  is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.
  See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo;
  and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 57%; font-size: 10pt">Large accelerated filer <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
      <TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
      <TD STYLE="width: 42%; font-size: 10pt">Accelerated filer <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt">Non-accelerated filer <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD>
      <TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD STYLE="font-size: 10pt">Smaller reporting company <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD STYLE="font-size: 10pt">Emerging growth company <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
  mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial or accounting
  standards pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>
  
  <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On March 7, 2024, the Board of
  Directors of Allarity Therapeutics, Inc. (the &ldquo;Registrant&rdquo;) approved an amendment and restatement of the Registrant&rsquo;s
  2021 Equity Incentive Plan (the &ldquo;Plan&rdquo;). Under the Plan, the number of shares of Common Stock that may be issued pursuant
  to the Plan was increased by 1,000,000 shares of common stock. This Registration Statement on Form S-8 (the &ldquo;Registration Statement&rdquo;)
  is filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) for the purposes of (i) registering 295,751 shares
  of the Registrant&rsquo;s common stock issuable under the Plan, which were added on January 1, 2024 as a result of an automatic annual
  increase provision therein and (ii) registering additional 1,000,000 shares of the Registrant&rsquo;s common stock issuable under the
  Plan.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART I</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The documents containing the
  information specified in Part I of Form S-8 will be sent or given to participants, as specified by Rule 428(b)(1) under the Securities
  Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). Such documents need not be filed with the Commission either as part of this
  Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. These documents and
  the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of Form S-8, taken together, will
  constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Part
  </B></FONT><B>II</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 3. Incorporation of Certain Documents
  by Reference.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents filed
  by the Registrant with the Commission are incorporated by reference into this Registration Statement:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Our Annual Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1860657/000121390024020864/ea0200752-10k_allarity.htm">Form 10-K</A> for the fiscal year ended December
  31, 2023, filed with the Commission on March 8, 2024;</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Our Current Reports on Form 8-K, filed with the Commission
  on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1860657/000121390024024156/ea0202127-8k_allarity.htm">March 20, 2024</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1860657/000121390024022845/ea0201874-8k_allarity.htm">March 15, 2024</A>; and</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">The description of our common stock contained in <A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000121390023019295/f10k2022ex4vi_allarity.htm">Exhibit 4(vi)</A>
  to our Annual Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1860657/000121390023019295/f10k2022_allaritytherap.htm">Form 10-K</A> filed with the Commission on March 13, 2023, including any amendments thereto or reports filed for
  the purpose of updating such description.</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, all documents
  subsequently filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act of 1934,
  as amended (the &ldquo;Exchange Act&rdquo;) (other than those furnished pursuant to Item 2.02 or Item 7.01 of Form 8-K or other information
  &ldquo;furnished&rdquo; to the Commission), prior to the filing of a post-effective amendment to this Registration Statement that indicates
  that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated
  by reference in this Registration Statement and to be part hereof from the time of filing of such documents.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Registration
  Statement, any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified
  or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently
  filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so
  modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
  Subject to the foregoing, all information in this Registration Statement is so qualified in its entirety by the information appearing
  in the documents incorporated herein by reference.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
  
  <!-- Field: Page; Sequence: 4; Options: NewSection -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 4. Description of Securities.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5. Interests of Named Experts and Counsel.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 6. Indemnification of Directors and Officers.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Delaware
  law, our certificate of incorporation, as amended (the &ldquo;Certificate of Incorporation&rdquo;), and our amended and restated bylaws,
  as amended (the &ldquo;Bylaws&rdquo;), provide that we will, in certain situations, indemnify our directors and officers and may indemnify
  other employees and other agents to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations,
  to advancement, direct payment, or reimbursement of reasonable expenses (including attorneys&rsquo; fees and disbursements) in advance
  of the final disposition of the proceeding.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
  Certificate of Incorporation limits a director&rsquo;s liability to the fullest extent permitted under the Delaware General Corporation
  Law (&ldquo;DGCL&rdquo;). The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach
  of their fiduciary duties as directors, except for liability:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">for any breach of the director&rsquo;s duty of loyalty to
  the corporation or its stockholders;</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">for acts or omissions not in good faith or which involve intentional
  misconduct or a knowing violation of law;</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">for unlawful payment of dividend or unlawful stock purchase
  or redemption pursuant to the provisions of Section 174 of the DGCL; and</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">for any transaction from which the director derived an improper
  personal benefit.</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Section
  145(a) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party to, or is threatened to be
  made a party to, any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative
  (other than an action by or in the right of the corporation), because he or she is or was a director, officer, employee, or agent of the
  corporation, or is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation,
  partnership, joint venture, trust, or other enterprise, against expenses (including attorneys&rsquo; fees), judgments, fines, and amounts
  paid in settlement actually and reasonably incurred by the person in connection with such action, suit, or proceeding, if he or she acted
  in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation and, with
  respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Section
  145(b) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party, or is threatened to be made
  a party, to any threatened, pending, or completed action or suit by or in the right of the corporation to procure a judgment in its favor
  because the person is or was a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation
  as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, against expenses
  (including attorneys&rsquo; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such
  action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests
  of the corporation, except that no indemnification shall be made with respect to any claim, issue, or matter as to which he or she shall
  have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court
  determines that, despite the adjudication of liability but in view of all of the circumstances of the case, he or she is fairly and reasonably
  entitled to indemnity for such expenses that the Court of Chancery or other adjudicating court shall deem proper.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>
  
  <!-- Field: Page; Sequence: 5 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Section
  145(g) of the DGCL provides, in general, that a corporation may purchase and maintain insurance on behalf of any person who is or was
  a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation as a director, officer,
  employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise against any liability asserted against
  such person and incurred by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation
  would have the power to indemnify the person against such liability under Section 145 of the DGCL.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
  the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability
  of the directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
  addition, we intend to enter into separate indemnification agreements with our directors and officers. These agreements, among other things,
  require us to indemnify our directors and officers for certain expenses, including attorneys&rsquo; fees, judgments, fines, and settlement
  amounts incurred by a director or officer in any action or proceeding arising out of their services as one of our directors or officers
  or any other company or enterprise to which the person provides services at our request.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
  anticipate maintaining a directors&rsquo; and officers&rsquo; insurance policy pursuant to which our directors and officers are insured
  against liability for actions taken in their capacities as directors and officers. We believe these provisions in the Certificate of Incorporation
  and the Bylaws and these indemnification agreements are necessary to attract and retain qualified persons as directors and officers.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See also the Undertakings
  set forth in the response to Item 9 herein.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 7. Exemption from Registration Claim.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  <!-- Field: Page; Sequence: 6 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 8. Exhibits.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD COLSPAN="7" STYLE="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporated by Reference</B></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR>
      <TD STYLE="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom; width: 9%; text-indent: 0">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit<BR>
  Number</B></P></TD>
      <TD STYLE="padding: 0; text-align: center; width: 1%; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 42%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit Description</B></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; width: 1%; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 7%; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; width: 1%; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom; width: 10%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File<BR>
   Number</B></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; width: 1%; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom; width: 7%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; width: 1%; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 12%; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing<BR>
   Date</B></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; width: 1%; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 7%; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed<BR>
   Herewith</B></FONT></TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000121390021044035/fs42021ex3-1_allarityther.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Incorporation</FONT></A></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-258968</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 20, 2021</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000121390021050601/fs42021a1ex3-3_allarity.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment to the Certificate of Incorporation of Allarity Therapeutics, Inc.</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4/A</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-259484</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 29, 2021</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000121390023021463/ea175532-8kex3i_allarity.htm">Second Certificate of Amendment to Certificate of Incorporation of Allarity Therapeutics, Inc.</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-41160</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 20, 2023</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000121390023022572/ea175667ex3-1_allarity.htm">Third Certificate of Amendment to Certificate of Incorporation of Allarity Therapeutics, Inc.</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-41160</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 24, 2023</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000121390023052454/ea180985ex3-1_allarity.htm">Fourth Certificate of Amendment to Certificate of Incorporation of Allarity Therapeutics, Inc.</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-41160</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 28, 2023</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000121390021050601/fs42021a1ex4-1_allarity.htm">Specimen Common Stock Certificate of Allarity Therapeutics, Inc.</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4/A</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-259484</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 29, 2021</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000121390021053320/fs42021a2ex3-4_allarity.htm">Amended and Restated Bylaws of Allarity Therapeutics, Inc.</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4/A</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-259484</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 18, 2021</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000121390022038536/ea162649ex3-1_allarity.htm">Amendment No. 1 to Amended and Restated Bylaws of Allarity Therapeutics, Inc.</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-41160</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 11, 2022</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea020234301ex5-1_allarity.htm">Opinion of Venable LLP</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea020234301ex5-1_allarity.htm">Consent of Venable LLP (included in Exhibit 5.1)</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea020234301ex23-2_allarity.htm">Consent of Wolf &amp; Company, P.C., Independent Registered Public Accounting Firm</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_001">Power of Attorney (included on the signature page to the Registration Statement)</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1860657/000117494724000304/ea0200572-02.htm#T99010">Allarity Therapeutics, Inc. 2021 Equity Incentive Plan (as amended and restated as of March 7, 2024)</A></FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEF14A</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-41160</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appendix A</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="white-space: nowrap; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 8, 2024</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD></TR>
    <TR STYLE="background-color: White">
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: justify; text-indent: 0"><A HREF="ea020234301ex-fee_allarity.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table</FONT></A></TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; text-align: center; vertical-align: bottom; text-indent: 0">&nbsp;</TD>
      <TD STYLE="padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
    </TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 7 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9. Undertakings.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 0in; font-size: 10pt">&nbsp;</TD>
      <TD STYLE="width: 0.25in; font-size: 10pt; text-align: justify">(A)</TD>
      <TD STYLE="font-size: 10pt; text-align: justify">The undersigned registrant hereby undertakes:</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">To file, during any period in which offers or sales are being
  made, a post-effective amendment to the Registration Statement:</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">To include any prospectus required by Section 10(a)(3) of
  the Securities Act.</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">To reflect in the prospectus any facts or events arising
  after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in
  the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing,
  any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
  was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
  filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20%
  change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Filing Fee Tables&rdquo; table in the effective
  Registration Statement.</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(iii)</TD><TD STYLE="text-align: justify">To include any material information with respect to the plan
  of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration
  Statement.</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Provided</I>, <I>however</I>, that paragraphs
  (a)(1)(i) and (a)(1)(ii) do not apply if the registration statement is on Form S&ndash;8, and the information required to be included
  in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant
  pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">That, for the purpose of determining any liability under
  the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities
  offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">To remove from registration by means of a post-effective
  amendment any of the securities being registered which remain unsold at the termination of the offering.</TD>
  </TR></TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 0in">&nbsp;</TD>
      <TD STYLE="font-size: 10pt; width: 0.25in">(B)</TD>
      <TD STYLE="font-size: 10pt; text-align: justify">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&rsquo;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and where applicable, each filing of an employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 0in">&nbsp;</TD>
      <TD STYLE="font-size: 10pt; width: 0.25in">(C)</TD>
      <TD STYLE="font-size: 10pt; text-align: justify">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act, and is therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
  
  <!-- Field: Page; Sequence: 8 -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
      <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>SIGNATURES</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
  of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
  of filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
  in the City of Boston, State of Massachusetts on March 25, 2024.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="text-transform: uppercase"><B>ALLARITY THERAPEUTICS, INC.</B></FONT></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 63%; font-size: 10pt">&nbsp;</TD>
      <TD STYLE="width: 6%; font-size: 10pt">&nbsp;</TD>
      <TD STYLE="width: 31%; font-size: 10pt">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD>
      <TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">By: </TD>
      <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt">/s/ Thomas Jensen</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD STYLE="font-size: 10pt">Name: </TD>
      <TD STYLE="font-size: 10pt">Thomas Jensen</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD STYLE="font-size: 10pt">Title:</TD>
      <TD STYLE="font-size: 10pt">Chief Executive Officer</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POWER OF ATTORNEY</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each person whose signature
  appears below hereby constitutes and appoints Thomas Jensen and Joan Brown, and each of them, as such person&rsquo;s true and lawful attorney-in-fact
  and agent, each with full powers of substitution and re-substitution, for such person and in such person&rsquo;s name, place and stead,
  in any and all capacities, to sign any or all amendments (including post-effective amendments) to this Registration Statement, and to
  file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting
  unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite or necessary to
  be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and
  confirming all that said attorney-in-fact and agent or his or her substitute or substitutes, may lawfully do or cause to be done by virtue
  thereof.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
  of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date
  indicated.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
      <TD STYLE="width: 33%; border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; text-align: center"><B>Name</B></TD>
      <TD STYLE="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="width: 45%; border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; text-align: center"><B>Title</B></TD>
      <TD STYLE="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; text-align: center"><B>Date</B></TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">/s/&nbsp;Thomas Jensen</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">Chief Executive Officer and Director</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">March 25, 2024</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">Thomas Jensen</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">(Principal Executive Officer)</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">/s/&nbsp;Joan Brown</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">Chief Financial Officer</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">March 25, 2024</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">Joan Brown</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">(Principal Accounting and Financial Officer)</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">/s/&nbsp;Gerald McLaughlin</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">Chairman of the Board</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">March 25, 2024</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">Gerald McLaughlin</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">/s/&nbsp;Joe Vazzano</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">Director</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">March 25, 2024</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">Joe Vazzano</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">/s/&nbsp;Laura Benjamin&#9;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">Director</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">March 25, 2024</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">Laura Benjamin&#9;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt">&nbsp;</TD>
      <TD STYLE="padding: 0.25pt; text-align: center">&nbsp;</TD></TR>
    </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
  
  <!-- Field: Page; Sequence: 9; Options: Last -->
      <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "ea0202343-s8_allarity.htm", "description": "REGISTRATION STATEMENT", "secsgml_size_bytes": 85649}]
metadata_filer: {"company-data": {"conformed-name": "Allarity Therapeutics, Inc.", "cik": "0001860657", "assigned-sic": "2834", "organization-name": "03 Life Sciences", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-278214", "film-number": "24779689"}, "business-address": {"street1": "24 SCHOOL ST., 2ND FLOOR", "city": "BOSTON", "state": "MA", "zip": "02108", "phone": "401-426-4664"}, "mail-address": {"street1": "24 SCHOOL ST., 2ND FLOOR", "city": "BOSTON", "state": "MA", "zip": "02108"}}
text: As filed with the Securities and Exchange Commission
  on March 25, 2024
  Registration No. 333-
  UNITED
  STATES
  SECURITIES
  AND EXCHANGE COMMISSION
  WASHINGTON, D.C. 20549
  FORM
  S-8
  REGISTRATION STATEMENT
  UNDER THE SECURITIES
  ACT OF 1933
  Allarity
  Therapeutics, Inc.
  (Exact name of registrant as specified in its charter)
  Delaware
  87-2147982
  (State or other jurisdiction of
  incorporation or organization)
  (I.R.S. Employer
  Identification No.)
  24 School Street, 2
  nd
  Floor
  Boston, MA
  02108
  (Address of Principal Executive Offices)
  (Zip Code)
  Allarity Therapeutics, Inc. 2021 Equity Incentive
  Plan
  (Full title of the plan)
  Thomas Jensen
  Chief Executive Officer
  c/o Allarity Therapeutics, Inc.
  24 School Street, 2
  nd
  Floor
  Boston, MA 02108
  (401) 426-4664
  (Name, address and telephone number, including
  area code, of agent for service)
  Copy to:
  William N. Haddad, Esq.
  Arif Soto, Esq.
  Venable LLP
  151 W. 42
  nd
  Street, 49
  th
  Floor
  New York, NY 10036
  (212) 307-5500
  Indicate by check mark whether the registrant
  is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.
  See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company,"
  and "emerging growth company" in Rule 12b-2 of the Exchange Act.
  Large accelerated filer
  ☐
  Accelerated filer
  ☐
  Non-accelerated filer
  ☒
  Smaller reporting company
  ☒
  Emerging growth company
  ☒
  If an emerging growth company, indicate by check
  mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial or accounting
  standards pursuant to Section 7(a)(2)(B) of the Securities Act.
  ☐
  EXPLANATORY NOTE
  On March 7, 2024, the Board of
  Directors of Allarity Therapeutics, Inc. (the "Registrant") approved an amendment and restatement of the Registrant's
  2021 Equity Incentive Plan (the "Plan"). Under the Plan, the number of shares of Common Stock that may be issued pursuant
  to the Plan was increased by 1,000,000 shares of common stock. This Registration Statement on Form S-8 (the "Registration Statement")
  is filed with the Securities and Exchange Commission (the "Commission") for the purposes of (i) registering 295,751 shares
  of the Registrant's common stock issuable under the Plan, which were added on January 1, 2024 as a result of an automatic annual
  increase provision therein and (ii) registering additional 1,000,000 shares of the Registrant's common stock issuable under the
  Plan.
  PART I
  INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
  The documents containing the
  information specified in Part I of Form S-8 will be sent or given to participants, as specified by Rule 428(b)(1) under the Securities
  Act of 1933, as amended (the "Securities Act"). Such documents need not be filed with the Commission either as part of this
  Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. These documents and
  the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of Form S-8, taken together, will
  constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.
  1
  Part
  II
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  Item 3. Incorporation of Certain Documents
  by Reference.
  The following documents filed
  by the Registrant with the Commission are incorporated by reference into this Registration Statement:
  (a)
  Our Annual Report on
  Form 10-K
  for the fiscal year ended December
  31, 2023, filed with the Commission on March 8, 2024;
  (b)
  Our Current Reports on Form 8-K, filed with the Commission
  on
  March 20, 2024
  and
  March 15, 2024
  ; and
  (c)
  The description of our common stock contained in
  Exhibit 4(vi)
  to our Annual Report on
  Form 10-K
  filed with the Commission on March 13, 2023, including any amendments thereto or reports filed for
  the purpose of updating such description.
  In addition, all documents
  subsequently filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act of 1934,
  as amended (the "Exchange Act") (other than those furnished pursuant to Item 2.02 or Item 7.01 of Form 8-K or other information
  "furnished" to the Commission), prior to the filing of a post-effective amendment to this Registration Statement that indicates
  that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated
  by reference in this Registration Statement and to be part hereof from the time of filing of such documents.
  For purposes of this Registration
  Statement, any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified
  or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently
  filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so
  modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
  Subject to the foregoing, all information in this Registration Statement is so qualified in its entirety by the information appearing
  in the documents incorporated herein by reference.
  II-
  1
  Item 4. Description of Securities.
  Not applicable.
  Item 5. Interests of Named Experts and Counsel.
  Not applicable.
  Item 6. Indemnification of Directors and Officers.
  Delaware
  law, our certificate of incorporation, as amended (the "Certificate of Incorporation"), and our amended and restated bylaws,
  as amended (the "Bylaws"), provide that we will, in certain situations, indemnify our directors and officers and may indemnify
  other employees and other agents to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations,
  to advancement, direct payment, or reimbursement of reasonable expenses (including attorneys' fees and disbursements) in advance
  of the final disposition of the proceeding.
  The
  Certificate of Incorporation limits a director's liability to the fullest extent permitted under the Delaware General Corporation
  Law ("DGCL"). The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach
  of their fiduciary duties as directors, except for liability:
  ●
  for any breach of the director's duty of loyalty to
  the corporation or its stockholders;
  ●
  for acts or omissions not in good faith or which involve intentional
  misconduct or a knowing violation of law;
  ●
  for unlawful payment of dividend or unlawful stock purchase
  or redemption pursuant to the provisions of Section 174 of the DGCL; and
  ●
  for any transaction from which the director derived an improper
  personal benefit.
  Section
  145(a) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party to, or is threatened to be
  made a party to, any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative
  (other than an action by or in the right of the corporation), because he or she is or was a director, officer, employee, or agent of the
  corporation, or is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation,
  partnership, joint venture, trust, or other enterprise, against expenses (including attorneys' fees), judgments, fines, and amounts
  paid in settlement actually and reasonably incurred by the person in connection with such action, suit, or proceeding, if he or she acted
  in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation and, with
  respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.
  Section
  145(b) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party, or is threatened to be made
  a party, to any threatened, pending, or completed action or suit by or in the right of the corporation to procure a judgment in its favor
  because the person is or was a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation
  as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, against expenses
  (including attorneys' fees) actually and reasonably incurred by the person in connection with the defense or settlement of such
  action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests
  of the corporation, except that no indemnification shall be made with respect to any claim, issue, or matter as to which he or she shall
  have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court
  determines that, despite the adjudication of liability but in view of all of the circumstances of the case, he or she is fairly and reasonably
  entitled to indemnity for such expenses that the Court of Chancery or other adjudicating court shall deem proper.
  II-
  2
  Section
  145(g) of the DGCL provides, in general, that a corporation may purchase and maintain insurance on behalf of any person who is or was
  a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation as a director, officer,
  employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise against any liability asserted against
  such person and incurred by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation
  would have the power to indemnify the person against such liability under Section 145 of the DGCL.
  If
  the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability
  of the directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.
  In
  addition, we intend to enter into separate indemnification agreements with our directors and officers. These agreements, among other things,
  require us to indemnify our directors and officers for certain expenses, including attorneys' fees, judgments, fines, and settlement
  amounts incurred by a director or officer in any action or proceeding arising out of their services as one of our directors or officers
  or any other company or enterprise to which the person provides services at our request.
  We
  anticipate maintaining a directors' and officers' insurance policy pursuant to which our directors and officers are insured
  against liability for actions taken in their capacities as directors and officers. We believe these provisions in the Certificate of Incorporation
  and the Bylaws and these indemnification agreements are necessary to attract and retain qualified persons as directors and officers.
  See also the Undertakings
  set forth in the response to Item 9 herein.
  Item 7. Exemption from Registration Claim.
  Not applicable.
  II-
  3
  Item 8. Exhibits.
  Incorporated by Reference
  Exhibit
  Number
  Exhibit Description
  Form
  File
  Number
  Exhibit
  Filing
  Date
  Filed
  Herewith
  4.1
  Certificate of Incorporation
  S-4
  333-258968
  3.1
  August 20, 2021
  4.2
  Certificate of Amendment to the Certificate of Incorporation of Allarity Therapeutics, Inc.
  S-4/A
  333-259484
  3.3
  September 29, 2021
  4.3
  Second Certificate of Amendment to Certificate of Incorporation of Allarity Therapeutics, Inc.
  8-K
  001-41160
  3.1
  March 20, 2023
  4.4
  Third Certificate of Amendment to Certificate of Incorporation of Allarity Therapeutics, Inc.
  8-K
  001-41160
  3.1
  March 24, 2023
  4.5
  Fourth Certificate of Amendment to Certificate of Incorporation of Allarity Therapeutics, Inc.
  8-K
  001-41160
  3.1
  June 28, 2023
  4.6
  Specimen Common Stock Certificate of Allarity Therapeutics, Inc.
  S-4/A
  333-259484
  4.1
  September 29, 2021
  4.7
  Amended and Restated Bylaws of Allarity Therapeutics, Inc.
  S-4/A
  333-259484
  3.4
  October 18, 2021
  4.8
  Amendment No. 1 to Amended and Restated Bylaws of Allarity Therapeutics, Inc.
  8-K
  001-41160
  3.1
  July 11, 2022
  5.1
  Opinion of Venable LLP
  X
  23.1
  Consent of Venable LLP (included in Exhibit 5.1)
  X
  23.2
  Consent of Wolf & Company, P.C., Independent Registered Public Accounting Firm
  X
  24.1
  Power of Attorney (included on the signature page to the Registration Statement)
  X
  99.1
  Allarity Therapeutics, Inc. 2021 Equity Incentive Plan (as amended and restated as of March 7, 2024)
  DEF14A
  001-41160
  Appendix A
  March 8, 2024
  107
  Filing Fee Table
  X
  II-
  4
  Item 9. Undertakings.
  (A)
  The undersigned registrant hereby undertakes:
  (1)
  To file, during any period in which offers or sales are being
  made, a post-effective amendment to the Registration Statement:
  (i)
  To include any prospectus required by Section 10(a)(3) of
  the Securities Act.
  (ii)
  To reflect in the prospectus any facts or events arising
  after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in
  the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing,
  any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
  was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
  filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20%
  change in the maximum aggregate offering price set forth in the "Calculation of Filing Fee Tables" table in the effective
  Registration Statement.
  (iii)
  To include any material information with respect to the plan
  of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration
  Statement.
  Provided
  ,
  however
  , that paragraphs
  (a)(1)(i) and (a)(1)(ii) do not apply if the registration statement is on Form S–8, and the information required to be included
  in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant
  pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.
  (2)
  That, for the purpose of determining any liability under
  the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities
  offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
  (3)
  To remove from registration by means of a post-effective
  amendment any of the securities being registered which remain unsold at the termination of the offering.
  (B)
  The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
  (C)
  Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act, and is therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
  II-
  5
  SIGNATURES
  Pursuant to the requirements
  of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
  of filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
  in the City of Boston, State of Massachusetts on March 25, 2024.
  ALLARITY THERAPEUTICS, INC.
  By:
  /s/ Thomas Jensen
  Name:
  Thomas Jensen
  Title:
  Chief Executive Officer
  POWER OF ATTORNEY
  Each person whose signature
  appears below hereby constitutes and appoints Thomas Jensen and Joan Brown, and each of them, as such person's true and lawful attorney-in-fact
  and agent, each with full powers of substitution and re-substitution, for such person and in such person's name, place and stead,
  in any and all capacities, to sign any or all amendments (including post-effective amendments) to this Registration Statement, and to
  file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting
  unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite or necessary to
  be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and
  confirming all that said attorney-in-fact and agent or his or her substitute or substitutes, may lawfully do or cause to be done by virtue
  thereof.
  Pursuant to the requirements
  of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date
  indicated.
  Name
  Title
  Date
  /s/ Thomas Jensen
  Chief Executive Officer and Director
  March 25, 2024
  Thomas Jensen
  (Principal Executive Officer)
  /s/ Joan Brown
  Chief Financial Officer
  March 25, 2024
  Joan Brown
  (Principal Accounting and Financial Officer)
  /s/ Gerald McLaughlin
  Chairman of the Board
  March 25, 2024
  Gerald McLaughlin
  /s/ Joe Vazzano
  Director
  March 25, 2024
  Joe Vazzano
  /s/ Laura Benjamin
  Director
  March 25, 2024
  Laura Benjamin
  II-
  6